Source: Blood Research. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, ANTAGONISTAS, FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO)
ABNT
LIMA, Keli et al. Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches. Blood Research. Seoul: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s44313-025-00117-y. Acesso em: 30 abr. 2026. , 2025APA
Lima, K., Nogueira, F. L., Silva, C. S. M. R., Cavaglieri, R. de C., Rego, E. M., Costa-Lotufo, L. V., & Machado Neto, J. A. (2025). Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches. Blood Research. Seoul: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s44313-025-00117-yNLM
Lima K, Nogueira FL, Silva CSMR, Cavaglieri R de C, Rego EM, Costa-Lotufo LV, Machado Neto JA. Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches [Internet]. Blood Research. 2025 ; 60[citado 2026 abr. 30 ] Available from: https://doi.org/10.1007/s44313-025-00117-yVancouver
Lima K, Nogueira FL, Silva CSMR, Cavaglieri R de C, Rego EM, Costa-Lotufo LV, Machado Neto JA. Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches [Internet]. Blood Research. 2025 ; 60[citado 2026 abr. 30 ] Available from: https://doi.org/10.1007/s44313-025-00117-y
